Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value

Overview

Journal Curr Issues Mol Biol

Publisher MDPI

Specialty Molecular Biology

Date 2024 Jun 26

PMID 38921000

Authors

Safia Iqbal

Md Rezaul Karim

Shahnawaz Mohammad

Ramya Mathiyalagan

Md Niaj Morshed

Deok-Chun Yang

Hyocheol Bae

Esrat Jahan Rupa

Dong Uk Yang

Affiliations

Soon will be listed here.

Abstract

The PHLDA (pleckstrin homology-like domain family) gene family is popularly known as a potential biomarker for cancer identification, and members of the PHLDA family have become considered potentially viable targets for cancer treatments. The PHLDA gene family consists of PHLDA1, PHLDA2, and PHLDA3. The predictive significance of PHLDA genes in cancer remains unclear. To determine the role of pleckstrin as a prognostic biomarker in human cancers, we conducted a systematic multiomics investigation. Through various survival analyses, pleckstrin expression was evaluated, and their predictive significance in human tumors was discovered using a variety of online platforms. By analyzing the protein-protein interactions, we also chose a collection of well-known functional protein partners for pleckstrin. Investigations were also carried out on the relationship between pleckstrins and other cancers regarding mutations and copy number alterations. The cumulative impact of pleckstrin and their associated genes on various cancers, Gene Ontology (GO), and pathway analyses were used for their evaluation. Thus, the expression profiles of PHLDA family members and their prognosis in various cancers may be revealed by this study. During this multiomics analysis, we found that among the PHLDA family, PHLDA1 may be a therapeutic target for several cancers, including kidney, colon, and brain cancer, while PHLDA2 can be a therapeutic target for cancers of the colon, esophagus, and pancreas. Additionally, PHLDA3 may be a useful therapeutic target for ovarian, renal, and gastric cancer.

References

Powis G, Meuillet E, Indarte M, Booher G, Kirkpatrick L . Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease. Biomed Pharmacother. 2023; 165:115024. DOI: 10.1016/j.biopha.2023.115024. View

Li G, Wang X, Hibshoosh H, Jin C, Halmos B . Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1. PLoS One. 2014; 9(9):e106349. PMC: 4169529. DOI: 10.1371/journal.pone.0106349. View

Ma Z, Lou S, Jiang Z . PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway. Aging (Albany NY). 2020; 12(9):7985-8000. PMC: 7244065. DOI: 10.18632/aging.103117. View

Peng X, Yang R, Song J, Wang X, Dong W . Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis the Wnt/β-Catenin Signaling Pathway. Front Med (Lausanne). 2022; 9:783592. PMC: 9189366. DOI: 10.3389/fmed.2022.783592. View

Saha S, Islam S, Kwak K, Rahman M, Cho S . PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther. 2019; 27(3-4):147-167. PMC: 7170805. DOI: 10.1038/s41417-019-0109-7. View

Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D . ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004; 6(1):1-6. PMC: 1635162. DOI: 10.1016/s1476-5586(04)80047-2. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Kumar A, Purohit R . Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain. PLoS One. 2013; 8(5):e64364. PMC: 3669323. DOI: 10.1371/journal.pone.0064364. View

Johnson E, Chang K, de Pablo Y, Ghosh S, Mehta R, Badve S . PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. J Cell Sci. 2011; 124(Pt 16):2711-22. DOI: 10.1242/jcs.084970. View

10.

Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R . Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020; 5(1):213. PMC: 7511340. DOI: 10.1038/s41392-020-00315-3. View

11.

Liu J, Liu X, Hui X, Cai L, Li X, Yang Y . Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy. J Am Heart Assoc. 2019; 8(16):e011830. PMC: 6759890. DOI: 10.1161/JAHA.118.011830. View

12.

Neef R, Kuske M, Prols E, Johnson J . Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res. 2002; 62(20):5920-9. View

13.

Saffarzadeh N, Ghafouri-Fard S, Rezaei Z, Aghazadeh K, Yazdani F, Mohebi M . Expression Analysis of and in Head and Neck Squamous Cell Carcinoma. Cancer Manag Res. 2020; 12:4085-4096. PMC: 7276198. DOI: 10.2147/CMAR.S252962. View

14.

Haslam R, Koide H, Hemmings B . Pleckstrin domain homology. Nature. 1993; 363(6427):309-10. DOI: 10.1038/363309b0. View

15.

Dave B, Mittal V, Tan N, Chang J . Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res. 2012; 14(1):202. PMC: 3496111. DOI: 10.1186/bcr2938. View

16.

Mizuno H, Kitada K, Nakai K, Sarai A . PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009; 2:18. PMC: 2689870. DOI: 10.1186/1755-8794-2-18. View

17.

Brader G, Compant S, Mitter B, Trognitz F, Sessitsch A . Metabolic potential of endophytic bacteria. Curr Opin Biotechnol. 2014; 27:30-7. PMC: 4045207. DOI: 10.1016/j.copbio.2013.09.012. View

18.

Hossain G, Lynn E, Maclean K, Zhou J, Dickhout J, Lhotak S . Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression. J Am Heart Assoc. 2013; 2(3):e000134. PMC: 3698773. DOI: 10.1161/JAHA.113.000134. View

19.

Chou W, Liu K, Shih Y, Chuang Y, Chou J, Lu H . Ouabain Induces Apoptotic Cell Death Through Caspase- and Mitochondria-dependent Pathways in Human Osteosarcoma U-2 OS Cells. Anticancer Res. 2017; 38(1):169-178. DOI: 10.21873/anticanres.12205. View

20.

Mi H, Muruganujan A, Casagrande J, Thomas P . Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013; 8(8):1551-66. PMC: 6519453. DOI: 10.1038/nprot.2013.092. View